Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Kjell E. Oberg"'
Autor:
Thorvardur Ragnar Halfdanarson, Diane Lauren Reidy, Namrata Vijayvergia, Daniel M. Halperin, Grace Goldstein, Grace Kong, Michael Michael, Simone Leyden, Simona Grozinsky-Glasberg, Halfdan Sorbye, Kjell E. Oberg, Cristina Sierras, Philip Harris
Publikováno v:
Journal of Clinical Oncology. 40:TPS514-TPS514
TPS514 Background: Gastroenteropancreatic neuroendocrine tumors (GEP-NETs), which represent approximately 70% of NETs, frequently develop metastatic disease with limited treatment options. Current standard therapies for well-differentiated high grade
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::91755899e4c1047ec10ebc87a8b233da
https://doi.org/10.1200/jco.2022.40.4_suppl.tps514
https://doi.org/10.1200/jco.2022.40.4_suppl.tps514
Autor:
Stacie Hudgens, Jonathon Gable, Matthew H. Kulke, Emily Bergsland, Lowell Brian Anthony, Martyn E. Caplin, Kjell E. Oberg, Marianne Pavel, Phillip Banks, Qi Melissa Yang, Pablo Lapuerta
Publikováno v:
Journal of Clinical Oncology. 35:e15132-e15132
e15132 Background: Telotristat ethyl is a tryptophan hydroxylase inhibitor in development for the treatment of carcinoid syndrome (CS) in patients who receive somatostatin analog (SSA) therapy. In TELESTAR, a pivotal Phase 3 study, telotristat ethyl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ceca0122191c5b2484fdaf84231bcbf
https://doi.org/10.1200/jco.2017.35.15_suppl.e15132
https://doi.org/10.1200/jco.2017.35.15_suppl.e15132
Autor:
Jonathan R. Strosberg, Edward M. Wolin, Beth Chasen, Matthew H. Kulke, David L Bushnell, Martyn E. Caplin, Richard P. Baum, Timothy J. Hobday, Andrew Eugene Hendifar, Kjell E. Oberg, Maribel Lopera Sierra, Dik J. Kwekkeboom, Philippe B. Ruszniewski, Eric Krenning, Pamela L. Kunz
Publikováno v:
Journal of Clinical Oncology. 34:4005-4005
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5b5690fdf391ce71285f061d68256a10
https://doi.org/10.1200/jco.2016.34.15_suppl.4005
https://doi.org/10.1200/jco.2016.34.15_suppl.4005
Autor:
Rachel M. McKenna, Kjell E. Oberg
Publikováno v:
Journal of Interferon & Cytokine Research. 17:141-143
Antibodies to interferon-alpha (IFN-alpha) are found in some patients being treated with this cytokine. In studies in which two recombinant IFN-alpha preparations were directly compared in cancer patients, those given IFN-alpha2a were found to have n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbc3bb495d41fcc267feaf0f31a4f521
https://doi.org/10.1089/jir.1997.17.141
https://doi.org/10.1089/jir.1997.17.141
Autor:
Marie-Louise H, Fjällskog, Margareta H, Lejonklou, Kjell E, Oberg, Barbro K, Eriksson, Eva T, Janson
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 9(4)
Molecular targeting with monoclonal antibodies and tyrosine kinase inhibitors is a novel approach to cancer treatment. We have examined the expression of molecular targets in patients with malignant endocrine pancreatic tumors, which is necessary to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a9d6bdec170cfc788d00eefd33ce712b
https://pubmed.ncbi.nlm.nih.gov/12684421
https://pubmed.ncbi.nlm.nih.gov/12684421
Autor:
Eva M. Tiensuu Janson, Kjell E. Oberg
Publikováno v:
Bailliere's clinical gastroenterology. 10(4)
Carcinoid tumours offer a diagnostic and therapeutic challenge. Although new biochemical markers and improved methods for tumour detection, including PET and somatostatin receptor scintigraphy, have been developed during the last two decades many pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf85ba9d9c7384f6b971904655585b04
https://pubmed.ncbi.nlm.nih.gov/9113314
https://pubmed.ncbi.nlm.nih.gov/9113314
Autor:
Staffan V Welin, Eva Tiensuu Janson, Anders Sundin, Mats Stridsberg, Erik Lavenius, Dan Granberg, Britt Skogseid, Kjell E Oberg, Barbro K Eriksson
Publikováno v:
European Journal of Endocrinology; Jul2004, Vol. 151 Issue 1, p0107-0112, 6p